News Release

<< Back

Surmodics to Host Virtual Shareholder Meeting on February 17

Webcast is Live at 4:00 p.m. (CT)

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Feb. 16, 2016-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Wednesday, February 17, at 4:00 p.m. CT (5:00 p.m. ET).

Gary Maharaj, chief executive officer, and Sue Knight, chair of the board, will provide a brief update on our business and key strategic initiatives underway at the Company.

To access the webcast, go to www.virtualshareholdermeeting.com/SRDX16 five minutes prior to the start of the meeting to log in. In addition, the Annual Meeting audio presentation will be archived on the Company’s website following the meeting.

About Surmodics, Inc.

Surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. Surmodics’ mission is to be a trusted partner to its customers by providing the most advanced surface modification technologies and in vitro diagnostic chemical components that help enhance the well-being of patients. The company’s core offerings include surface modification coating technologies that impart lubricity, prohealing and biocompatibility characteristics and components for in vitro diagnostic test kits and microarrays. Surmodics’ strategy is to build on the product and technical leadership within these fields, and expand the core offerings to generate opportunities for longer term sustained growth. Surmodics is headquartered in Eden Prairie, Minnesota. For more information about the Company, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the Company makes with the SEC.

Source: Surmodics, Inc.

Surmodics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com